Edgewise Therapeutics, Inc. (EWTX) Misses Q2 EPS by 6c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q2 EPS of ($0.53), $0.06 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Honda and Nissan to jointly develop vehicle sofware, Nikkei reports
• Agnico Eagle subsidiary adds to Canada Nickel stake via private placement